Indapamide: Clinical Trials

5 trials of Indapamide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 5

Follow Indapamide: new trials by email Literature Review of Indapamide trials Research Report on Indapamide

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment Optimisation for Blood Pressure With Single-Pill Combinations in India
Amlodipine + Perindopril, Perindopril + Indapamide, Amlodipine + Indapamide - Primary Hypertension
Phase 4CompletedCentre for Chronic Disease Control, India19812022-08-302024-10-08
Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal Insufficiency
Indapamide, Hydrochlorothiazide - Hypertension, Renal Insufficiency
Phase 4CompletedWest China Hospital2402010-09-012014-06-24
A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM
Hydrochlorothiazide, Indapamide - Hypertension, Type 2 Diabetes Mellitus
Phase 4CompletedLaborMed Pharma S.A.562008-03-012011-06-15
IDEAL Study: Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering Drugs
Indapamide (T2), Perindopril (T1), Placebo of Perindopril (P1) - Hypertension
Phase 4CompletedHospices Civils de Lyon1392004-10-012025-12-19
Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy
Ambulatory blood pressure monitoring, Chronotherapy, timing of antihypertensive medication, ACEI (including spirapril, enalapril, quinapril, lisinopril) - Hypertension
Phase 4CompletedUniversity of Vigo33442000-03-012009-04-28

Conditions studied

Hypertension (4)  ·  Diabetes Mellitus, Type 2 (1)  ·  Essential Hypertension (1)  ·  Renal Insufficiency (1)

Sponsors

Centre for Chronic Disease Control, India (1)  ·  Hospices Civils de Lyon (1)  ·  LaborMed Pharma S.A. (1)  ·  University of Vigo (1)  ·  West China Hospital (1)

Countries

China (1)  ·  France (1)  ·  India (1)  ·  Romania (1)  ·  Spain (1)

Top investigators

Dorairaj Prabhakaran, DM Cardiology (1)  ·  Dragos Vinereanu, Professor, MD, PhD (1)  ·  Ramon C Hermida, PhD (1)  ·  Xiao P Chen, master (1)

Results publications

PMID 19407805, PMID 21617110, PMID 21884956, PMID 24739801, PMID 26399404, PMID 40715816